TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
SVRA

Savara Inc

Healthcare · Biotechnology

4.80$ -0.6% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Savara Inc (SVRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 192 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SVRA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
40 29 14 126 119 160 129 118 155 152 148 147 141 136 120 115 109 98 208 196 187 177 166 157 148 140 129 120 182 178 158 140 239 213 189 164 141 253 222 192
28 15 8.2 64 56 98 88 77 115 113 108 114 108 124 107 103 96 85 195 183 175 165 155 145 137 129 118 108 170 166 146 128 226 202 177 151 128 242 209 178
21 13 7.8 61 20 22 22 24 25 24 26 17 18 50 35 47 35 23 56 41 45 34 79 95 120 52 34 23 28 27 17 24 21 15 20 17 16 33 39 42
27 13 7.8 61 53 94 85 75 112 111 105 112 106 122 105 100 94 82 193 181 171 161 152 142 134 126 115 105 168 162 143 122 219 196 173 146 124 236 203 173
– 0.9 0.4 1.2 0.5 1.0 1.0 1.1 1.2 1.7 1.5 1.7 1.4 1.6 1.6 1.7 0.5 1.7 1.4 1.5 1.2 1.1 1.1 0.9 0.9 1.0 1.0 1.0 1.0 1.0 0.9 1.0 1.2 1.0 1.0 1.1 1.1 1.3 1.1 1.1
0.0 0.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 – – – – – – – – – – – – -1.1 – – – 2.1 1.6 1.6 0.7 0.0 1.7 – – – – – – – – –
0.1 0.1 0.1 0.7 0.6 0.9 0.8 0.7 0.6 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 – 0.0 0.3 – – – – – – – – – – – –
3.0 3.1 3.0 28 28 27 27 27 27 27 27 19 19 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – –
8.5 10 2.5 33 33 34 12 12 12 11 11 11 11 11 11 11 12 12 12 12 12 11 11 10 9.8 11 11 11 10 11 11 11 11 10 11 12 12 12 11 11
27 65 9.5 46 44 40 35 35 37 152 46 35 34 35 33 31 33 33 33 31 32 32 30 30 31 32 31 32 36 37 36 38 39 41 41 43 47 50 46 48
21 3.5 6.6 8.1 6.1 6.0 5.4 7.5 11 7.3 8.9 9.1 8.3 11 7.7 6.5 7.6 8.2 7.2 5.6 11 15 16 3.7 5.2 5.9 4.9 5.9 9.0 11 9.8 11 13 15 12 14 17 20 16 18
12 2.0 1.6 0.7 0.3 0.3 0.0 2.2 4.1 0.0 0.7 0.7 0.6 2.4 0.3 0.3 0.2 0.2 0.1 0.1 4.3 8.5 13 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 –
1.5 0.5 0.5 1.9 1.7 2.8 3.4 2.5 3.2 3.9 3.5 4.4 2.9 3.4 1.2 2.0 1.7 2.6 2.7 2.1 1.3 1.4 1.3 0.8 0.9 1.3 1.6 2.5 3.2 3.5 2.9 3.4 4.6 4.5 5.6 4.7 4.1 5.8 4.5 7.0
2.6 2.3 1.9 15 15 15 15 13 11 25 25 25 25 23 25 25 25 25 25 25 21 17 13 26 26 26 26 26 26 26 26 26 27 27 30 30 30 30 30 30
13 -36 4.4 80 75 119 94 83 118 108 102 113 107 102 87 84 77 64 175 165 155 144 136 127 117 108 98 88 147 140 122 102 199 171 148 120 94 203 176 144
-305 -38 -317 -55 -62 -68 -95 -107 -119 -130 -142 -164 -176 -208 -223 -233 -244 -258 -268 -279 -289 -301 -309 -318 -328 -339 -349 -361 -377 -393 -414 -436 -460 -489 -516 -546 -576 -608 -645 -686
3.1 3.5 3.0 14 24 29 31 31 34 36 36 38 42 44 57 59 60 60 77 152 153 153 153 153 153 153 153 153 164 180 183 183 212 198 216 216 216 222 253 254

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?